PDT Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-35,218	Closed	-$2.41M	–	845
2024 Q2	$2.41M	Sell	35,218 -15,714	-31%	-$1.09M	0.23%	158
2024 Q1	$3.52M	Sell	50,932 -7,406	-13%	-$509K	0.33%	83
2023 Q4	$4.18M	Sell	58,338 -12,114	-17%	-$697K	0.46%	45
2023 Q3	$3.67M	Buy	70,452 +14	+0%	+$816	0.46%	45
2023 Q2	$4.46M	Sell	70,438 -9,428	-12%	-$587K	0.61%	16
2023 Q1	$4.32M	Buy	79,866 +24,657	+45%	+$1.19M	0.59%	7
2022 Q4	$2.92M	Buy	55,209 +41,716	+309%	+$2.09M	0.47%	30
2022 Q3	$628K	Buy	+13,493	New	+$705K	0.1%	365
2020 Q1	–	Sell	-6,229	Closed	-$214K	–	885
2019 Q4	$214K	Sell	6,229 -123,512	-95%	-$1.48M	0.01%	631
2019 Q3	$969K	Buy	129,741 +84,537	+187%	+$811K	0.06%	285
2019 Q2	$587K	Buy	+45,204	New	+$580K	0.03%	295
2018 Q2	–	Sell	-115,700	Closed	-$2.44M	–	589
2018 Q1	$2.44M	Sell	115,700 -18,254	-14%	-$356K	0.08%	247
2017 Q4	$1.94M	Buy	133,954 +66,154	+98%	+$1.02M	0.06%	305
2017 Q3	$1.07M	Sell	67,800 -10,300	-13%	-$151K	0.04%	348
2017 Q2	$970K	Sell	78,100 -13,084	-14%	-$152K	0.04%	344
2017 Q1	$1.48M	Sell	91,184 -173	-0.2%	-$2.5K	0.08%	268
2016 Q4	$1.38M	Buy	+91,357	New	+$1.29M	0.09%	290